Stocks:
5,168
ETFs:
2,288
Exchanges:
11
Market Cap:
$65.69T
24h Vol:
$10.68B
Dominance:
MSFT:4.75%
Stocklytics Platform
Asset logo  CLBTW
Cellebrite DI Ltd.
CLBTW
4 / 100
$2.66arrow_drop_up1.91%$0.05

Performance History

Stocklytics logo
Key Stats
Open$2.64
Prev. Close$2.44
EPS0.056
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap-
PE Ratio45.54
LOWHIGH
Day Range2.53
2.65
52 Week Range0.72
2.80
Ratios
P/B Ratio0.00
Revenue-
Operating M. %16.78%
Earnings$0.00
Earnings Growth %-167.13%
EBITDA Margin %13.52%
ROE %-150.08%
EPS0.056

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$356.26
24H (%)arrow_drop_up1.58%
24H ($)$5.54
MARKET CAP$174.23B
PRICE$359.29
24H (%)arrow_drop_down1.37%
24H ($)-$5.00
MARKET CAP$50.05B
Placeholder
PRICE$24.00
24H (%)arrow_drop_up0.20%
24H ($)$0.05
MARKET CAP$37.20B
PRICE$23.22
24H (%)0.00%
24H ($)$0.00
MARKET CAP$36.52B

About Cellebrite DI Ltd. (CLBTW)

No data available
Sector
-
Industry
-
CEO
-
Headquarters
-
Employees
0
Exchange
NASDAQ
add Cellebrite DI Ltd. to watchlist

Keep an eye on Cellebrite DI Ltd.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Cellebrite DI Ltd.'s (CLBTW) price per share?

The current price per share for Cellebrite DI Ltd. (CLBTW) is $2.66. The stock has seen a price change of $0.05 recently, indicating a 1.92% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Cellebrite DI Ltd. (CLBTW)?

For Cellebrite DI Ltd. (CLBTW), the 52-week high is $2.8, which is 5.26% from the current price. The 52-week low is $0.72, the current price is 269.44% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Cellebrite DI Ltd. (CLBTW) a growth stock?

Cellebrite DI Ltd. (CLBTW) has shown an average price growth of 0.41% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Cellebrite DI Ltd. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Cellebrite DI Ltd. (CLBTW) stock price performance year to date (YTD)?

As of the latest data, Cellebrite DI Ltd. (CLBTW) has a year-to-date price change of 69.43%. Over the past month, the stock has experienced a price change of 41.49%. Over the last three months, the change has been 13.19%. Over the past six months, the figure is 90%.

help
Is Cellebrite DI Ltd. (CLBTW) a profitable company?

Cellebrite DI Ltd. (CLBTW) has a net income of -$81.1M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 83.63% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 16.78% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 20.12%, providing insight into the company's sales performance and growth. The gross profit is $271.88M. Operating income is noted at $33.28M. Furthermore, the EBITDA is $43.95M.

help
What is the market capitalization of Cellebrite DI Ltd. (CLBTW)?

Cellebrite DI Ltd. (CLBTW) has a market capitalization of . The average daily trading volume is 53.28K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level